Comment on: “UGT2B17 modifies drug response in chronic lymphocytic leukaemia”

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1: ERV onco-exaptation drives UGT2B17 ectopic transcription.


  1. 1.

    Allain, E. P., Rouleau, M., Vanura, K., Tremblay, S., Vaillancourt, J., Bat V. et al. UGT2B17 modifies drug response in chronic lymphocytic leukaemia. Br. J. Cancer (2020).

  2. 2.

    Gruber, M., Bellemare, J., Hoermann, G., Gleiss, A., Porpaczy, E., Bilban, M. et al. Overexpression of uridine diphospho glucuronosyltransferase 2B17 in high-risk chronic lymphocytic leukemia. Blood 121, 1175–1183 (2013).

    CAS  Article  Google Scholar 

  3. 3.

    Kassiotis, G. Endogenous retroviruses and the development of cancer. J. Immunol. 192, 1343–1349 (2014).

    CAS  Article  Google Scholar 

  4. 4.

    van de Lagemaat, L. N., Landry, J. R., Mager, D. L. & Medstrand, P. Transposable elements in mammals promote regulatory variation and diversification of genes with specialized functions. Trends Genet. 19, 530–536 (2003).

    Article  Google Scholar 

  5. 5.

    Babaian, A. & Mager, D. L. Endogenous retroviral promoter exaptation in human cancer. Mob. DNA 7, 24 (2016).

    Article  Google Scholar 

  6. 6.

    Smit, A., Hubley, R. & Green P. RepeatMasker Open-3.0. (1996–2010).

  7. 7.

    ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57–74 (2012).

    Article  Google Scholar 

  8. 8.

    Phillips, J. E. & Corces, V. G. CTCF: master weaver of the genome. Cell 137, 1194–1211 (2009).

    Article  Google Scholar 

  9. 9.

    Furman, R. R., Asgary, Z., Mascarenhas, J. O., Liou, H. C. & Schattner, E. J. Modulation of NF-kappa B activity and apoptosis in chronic lymphocytic leukemia B cells. J. Immunol. 164, 2200–2206 (2000).

    CAS  Article  Google Scholar 

  10. 10.

    Oakes, C. C., Claus, R., Gu, L., Assenov, Y., Hullein, J., Zucknick, M. et al. Evolution of DNA methylation is linked to genetic aberrations in chronic lymphocytic leukemia. Cancer Discov. 4, 348–361 (2014).

    CAS  Article  Google Scholar 

Download references


S.I.P. gratefully acknowledges Professor George Kassiotis at the Francis Crick Institute for the enlightening discussion on endogenous retroviruses during the EMBO|EMBL Symposium “The Mobile Genome” and the fruitful mentoring provided ever since.

Author information




Conception and design of the work: S.I.P. Data collection: S.I.P. Data analysis and interpretation: S.I.P. Drafting of the paper: S.I.P., C.J. Supervision of the work: C.J. Critical revision of the article: S.I.P., C.J.

Corresponding author

Correspondence to Spyros I. Papamichos.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Data availability

The ChIP-seq data reported in this study represent publicly available material, generated from the Encyclopaedia of DNA Elements (ENCODE) Consortium, and are archived at the UCSC Genome Browser Database (

Competing interests

The authors declare no competing interests.

Funding information

The authors have not received any funding.

Additional information

Note This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Papamichos, S.I., Jungbauer, C. Comment on: “UGT2B17 modifies drug response in chronic lymphocytic leukaemia”. Br J Cancer (2020).

Download citation